Monoclonal antibody JSB‐1 detects a highly conserved epitope on the P‐glycoprotein associated with multi‐drug‐resistance

R. J. Scheper, J. W.M. Bulte, J. G.P. Brakkee, J. J. Quak, E. van der Schoot, A. J.M. Balm, C. J.L.M. Melier, H. J. Broxteman, C. M. Kuiper, J. Lankelma, H. M. Pinedo

Research output: Contribution to journalArticlepeer-review

Abstract

Resistance to multiple chemotherapeutic agents is a common clinical problem in the treatment of cancer. This resistance may occur before primary therapy or be acquired during treatment. We have generated a monoclonal antibody (MAb) (JSB‐I), specific for a conserved epitope on the plasma membrane 170‐ to 180‐kDa glycoprotein, the expression of which is strongly correlated with the degree of multi‐drug resistance (MDR). JSB‐1 strongly binds to both Chinese‐hamster‐derived MDR cell lines and human MDR cell lines, including cell lines derived from lung and ovary. A drug‐sensitive revertant line, and the corresponding drug‐sensitive parent lines, showed only weak reactivity or none at all. JSS‐l reacts strongly to air‐dried or acetone‐fixed cells and therefore has potential value for diagnostic detection of MDR cells in human tumor samples.

Original languageEnglish (US)
Pages (from-to)389-394
Number of pages6
JournalInternational Journal of Cancer
Volume42
Issue number3
DOIs
StatePublished - Sep 15 1988
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Monoclonal antibody JSB‐1 detects a highly conserved epitope on the P‐glycoprotein associated with multi‐drug‐resistance'. Together they form a unique fingerprint.

Cite this